Showing results (871-880 of 2,061) with videos related to
Sort By:
Pageof 207
Brachytherapy|May 22, 2019
High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decayChristopher J Tien, David J Carlson, Ravinder Nath, et al.Brachytherapy|June 8, 2019
Cosmetic assessment in brachytherapy (interventional radiotherapy) for breast cancer: A multidisciplinary reviewLuca Tagliaferri, Valentina Lancellotta, Tiziano Zinicola, et al.Brachytherapy|October 4, 2021
Computed tomography-guided partial-breast brachytherapy using implanted catheters as fiducial markers versus co-registered magnetic resonance imagingKazuhiko Sato, Takahiro Shimo, Masahiro Kato, et al.Brachytherapy|October 8, 2021
Demographic and clinical factors associated with variations in opioid administration using conscious sedation during HDR brachytherapy for cervical cancerJessica M Wilson, Erik Davies, Xianming Tan, et al.Brachytherapy|March 8, 2022
Impact of detector selection on commissioning of Leipzig surface applicators with improving immobilization in high-dose-rate brachytherapyXing Li, Fan-Chi Su, Vikren Sarkar, et al.Brachytherapy|March 25, 2022
Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapyManon Kissel, Arthur Pounou, Kanta Ka, et al.Brachytherapy|March 26, 2022
First pointwise encoding time reduction with radial acquisition (PETRA) implementation for catheter detection in interstitial high-dose-rate (HDR) brachytherapyEvangelia Kaza, Casey Y Lee, Martin T King, et al.Brachytherapy|June 5, 2019
Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysisLucas Gomes Sapienza, Matthew Stephen Ning, Antônio Cássio de Assis Pellizzon, et al.Brachytherapy|September 16, 2018
Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT imagesKibrom Berihu Girum, Alain Lalande, Magali Quivrin, et al.Brachytherapy|August 26, 2018
Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancerManuj Agarwal, Arpit M Chhabra, Neha Amin, et al.Pageof 207